Praised by athletes, weekend warriors, biohackers, and patients recovering from injury, BPC-157 has earned a reputation as the get-back-to-life molecule and for good reason
Green R, Datta Mitra A The Medical clinics of North America 2017
The FDA has identified concerns with compounded BPC-157, including possible immunogenicity risks, peptide-related impurities, and limited safety information for proposed routes of administration
In particolare, vengono sollevate domande sull'opportunit dell'uso in persone con storia oncologica, sebbene non vi siano dati conclusivi in nessuna direzione
Based on research protocols of 2-10 mcg/kg
The goal, here, is to prevent the publication of mistakes, fraud or sloppy work